News

Pennant Acquires Home Health Provider, Senior Living Real Estate Asset

EAGLE, Idaho, May 02, 2022 (GLOBE NEWSWIRE) -- The Pennant Group, Inc. (NASDAQ: PNTG), the parent company of the Pennant…

2 years ago

aTyr Pharma to Webcast Conference Call Reporting First Quarter 2022 Financial Results

Management to host conference call and webcast on May 9th at 5:00 pm EDT / 2:00 pm PDTSAN DIEGO, May…

2 years ago

Surrozen Presents Data Supporting Potential of SZN-413 for the Treatment of Diabetic Retinopathy at the Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting

Preclinical data suggest that SZN-413 can simultaneously address retinal non-perfusion and leakage in blood vessels in retinal vascular diseasesSOUTH SAN…

2 years ago

Avadel Pharmaceuticals to Provide a Corporate Update and Report First Quarter Financial Results on May 9

DUBLIN, Ireland, May 02, 2022 (GLOBE NEWSWIRE) -- Avadel Pharmaceuticals plc (Nasdaq: AVDL), a biopharmaceutical company focused on transforming medicines…

2 years ago

LifeMD to Announce First Quarter Financial Results and Host Conference Call on Friday, May 13

NEW YORK, May 02, 2022 (GLOBE NEWSWIRE) -- LifeMD, Inc. (NASDAQ: LFMD), a leading direct-to-patient telehealth company, today announced that…

2 years ago

Join the MS Community and Raise Awareness for MS this May

MS Society invites Canadians to participate in nationwide MS Awareness Month activities TORONTO, May 02, 2022 (GLOBE NEWSWIRE) -- For…

2 years ago

Vaxxinity Receives FDA Fast Track Designation for UB-311 for Treatment of Alzheimer’s Disease

DALLAS, May 02, 2022 (GLOBE NEWSWIRE) -- Vaxxinity, Inc. (Nasdaq: VAXX), a company pioneering the development of a new class…

2 years ago

Mersana Therapeutics to Host First Quarter 2022 Conference Call on May 9, 2022

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Mersana Therapeutics, Inc. (NASDAQ: MRSN), a clinical-stage biopharmaceutical company focused on discovering…

2 years ago

Fulcrum Therapeutics to Host First Quarter 2022 Financial Results Conference Call and Webcast on Monday, May 9, 2022 at 8:00 a.m. ET

CAMBRIDGE, Mass., May 02, 2022 (GLOBE NEWSWIRE) -- Fulcrum Therapeutics, Inc.® (Nasdaq: FULC), a clinical-stage biopharmaceutical company focused on improving the lives…

2 years ago

Gracell Biotechnologies to Report First Quarter 2022 Financial Results on Monday, May 16, 2022

SAN DIEGO, Calif., and SUZHOU, China, May 02, 2022 (GLOBE NEWSWIRE) -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) (“Gracell”), a global…

2 years ago